Research released by the Copenhagen Consensus Center yesterday identified TB as a key priority for infectious disease control in terms of cost effectiveness and disease burden. The paper points out that the majority of TB deaths occur among adults in their economically most productive years, which can be an instigator for a family falling into
The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) have jointly developed the ‘European Union Standards for Tuberculosis Care (ESTC)’, standards intended to guide clinicians and public health workers to delivery optimal prevention, diagnosis and treatment of TB. After gaps in case management were identified in a recent survey,
When Stefan returned to the Netherlands after a brief stay in the US some years ago, he was diagnosed with what he thought was a disease from the past: tuberculosis. Luckily for Stefan, the Netherlands has a very effective tuberculosis control program and he was cured. Watch how tuberculosis changed his life and what can
During the week of 19-25 March 2012, activities were organised by the TB Europe Coalition and other actors in Brussels to raise awareness on Tuberculosis among EU policy makers but also this year among the general public.
Exchange of Views on Drug-Resistant TB at the ENVI Committee of the European Parliament
On 21st March, the TB Europe
In run up to World TB Day on Saturday, 24th March, here are some events that are going on around Europe:
LONDON: APPG on Global TB: TB and Children, ‘Stop TB in my lifetime’
21 March
Children have weak immune systems, making them prime targets for TB and a significant number become sick and die from the disease
On January 28, 2012, the world marked the 10-year anniversary of the launch of the most successful global health effort in history — the Global Fund to Fight AIDS, Tuberculosis and Malaria. Since its creation in 2002, Global Fund financed projects have treated 8.6 million new cases of TB, provided life-saving antiretroviral treatment to 3.3
News of incurable cases of TB has cropped up in India, where at least 12 patients with TB did not respond to first or second-line drugs they were given. None of them have been successfully treated and three have died. These cases are being termed ‘totally drug-resistant tuberculosis’ or ‘TDR-TB’.
TB is normally treated with a
A giant condom will be ‘wrapped’ around the Dutch Munt Tower in Amsterdam this week. It’s probably one of the more striking activities that will mark World Aids Day. Meetings, film-viewings, theatre plays, articles, brochures and many other happenings will call upon people to join the fight against HIV and Aids. To effectively fight Aids
African and European research institutions are joining forces to strengthen research and development of tuberculosis (TB) vaccines. A new network brings together twelve institutions from both continents to improve collaboration, to set up joint activities and to exchange knowledge. The network, called TBTEA, has received a budget of 765,000 euros.
“TBTEA is an excellent networking opportunity,”
New data released by the Treatment Action Group (TAG) and the Stop TB Partnership finds that in 2010 the world spent just $617 million in tuberculosis (TB) research and development (R&D), or 0.3% less than 2009 funding levels—the first time TAG documents no growth since it began tracking TB research investments in 2005.
The report, Tuberculosis
“Elimination of tuberculosis (TB) is more than an aspiration. We know it could become a reality, but this will happen only if we achieve radical transformation in the way TB is diagnosed, treated and prevented. This goal can be realized only if TB research is intensified and envisioned in an entirely new way.” These are
